Aurisco Pharmaceutical Co.,Ltd. (605116.SS)
CNY 20.8
(-0.48%)
CNY 20.8
(-0.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.26 Billion | 1 Billion | 803.36 Million | 721.44 Million | 581.63 Million | 575.41 Million |
| Cost of Revenue | 564.21 Million | 487.67 Million | 408.64 Million | 380.53 Million | 283.27 Million | 304.62 Million |
| Gross Profit | 698.31 Million | 520.39 Million | 394.71 Million | 340.9 Million | 298.36 Million | 270.78 Million |
| Operating Expenses | 375.24 Million | 292.04 Million | 202.43 Million | 142.13 Million | 129.03 Million | 109.38 Million |
| Selling, General and Administrative Expenses | 147.18 Million | 90.04 Million | 71.05 Million | 45.92 Million | 51.08 Million | 44.61 Million |
| Research and Development Expenses | 136.88 Million | 117.26 Million | 69.35 Million | 47.35 Million | 35.1 Million | 24.65 Million |
| Other Expenses | -7.65 Million | 84.73 Million | 62.03 Million | 48.85 Million | 42.84 Million | -476.33 Thousand |
| Cost and Expenses | 931.8 Million | 779.72 Million | 611.08 Million | 522.67 Million | 412.3 Million | 414 Million |
| Operating Income | 330.72 Million | 241.27 Million | 193.62 Million | 187.27 Million | 170.71 Million | 164.65 Million |
| Interest Expense | 3.64 Million | 1.01 Million | 643.75 Thousand | 529.62 Thousand | 545.95 Thousand | 3045.00 |
| Income Tax Expense | 40.01 Million | 32.54 Million | 23.72 Million | 28.51 Million | 20.18 Million | 27.35 Million |
| Earnings before Tax | 329.07 Million | 240.75 Million | 192.01 Million | 185.73 Million | 206.31 Million | 164.18 Million |
| Net Income | 289.41 Million | 210.96 Million | 168.71 Million | 157.22 Million | 186.13 Million | 136.82 Million |
| Earnings Per Share Basic | 0.71 | 0.53 | 0.42 | 0.39 | 0.46 | 0.38 |
| Earnings Per Share Diluted | 0.71 | 0.53 | 0.42 | 0.39 | 0.46 | 0.38 |
| Weighted Average Shares Outstanding | 407.63 Million | 401 Million | 401 Million | 401 Million | 401 Million | 360.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 407.63 Million | 401 Million | 401 Million | 401 Million | 401 Million | 360.07 Million |
| Gross Margin | 0.55 | 0.52 | 0.49 | 0.47 | 0.51 | 0.47 |
| EBIT Margin | 0.33 | 0.32 | 0.31 | 0.32 | 0.34 | 0.33 |
| Profit Margin | 0.23 | 0.21 | 0.21 | 0.22 | 0.32 | 0.24 |
| EBITDA | 414.37 Million | 313.2 Million | 247.42 Million | 223.9 Million | 234.75 Million | 161.3 Million |
| Earnings Before Tax Margin | 0.26 | 0.24 | 0.24 | 0.26 | 0.29 | 0.29 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 357.66 Million | 394.01 Million | 335.62 Million | 340 Million | 1.26 Billion | 369.87 Million |
| Cost of Revenue | 140.62 Million | 165.9 Million | 155.45 Million | 147.31 Million | 556.55 Million | 131.77 Million |
| Gross Profit | 217.03 Million | 228.1 Million | 180.16 Million | 192.68 Million | 705.97 Million | 238.1 Million |
| Operating Expenses | 102.63 Million | 119.79 Million | 92.14 Million | 124.86 Million | 409.35 Million | 120.57 Million |
| Selling, General and Administrative Expenses | 123.61 Million | 86.4 Million | 61.47 Million | -16.53 Million | - | 126.13 Million |
| Research and Development Expenses | 39.93 Million | 33.38 Million | 28.93 Million | 41.1 Million | - | 39.87 Million |
| Other Expenses | -60.91 Million | 137.51 Thousand | -1.34 Million | -1.11 Million | -1.64 Million | 1.93 Million |
| Cost and Expenses | 243.26 Million | 285.7 Million | 247.6 Million | 272.17 Million | 965.9 Million | 252.35 Million |
| Operating Income | 108.5 Million | 108.3 Million | 100.44 Million | 65.39 Million | 330.72 Million | 147.36 Million |
| Interest Expense | 5.16 Million | 422.41 Thousand | 590.3 Thousand | 1.11 Million | 2.74 Million | 357.1 Thousand |
| Income Tax Expense | 13 Million | 10.85 Million | 16.92 Million | 7.93 Million | 40.01 Million | 11.21 Million |
| Earnings before Tax | 108.21 Million | 117.26 Million | 99.1 Million | 64.27 Million | 329.07 Million | 147.08 Million |
| Net Income | 95.2 Million | 106.4 Million | 82.18 Million | 56.87 Million | 289.41 Million | 136.64 Million |
| Earnings Per Share Basic | 0.24 | 0.26 | 0.20 | 0.47 | - | 0.34 |
| Earnings Per Share Diluted | 0.24 | 0.26 | 0.20 | 0.47 | - | 0.34 |
| Weighted Average Shares Outstanding | 402.03 Million | 402.03 Million | 410.92 Million | 415.69 Million | 407.63 Million | 401 Million |
| Weighted Average Shares Outstanding (Diluted) | 402.03 Million | 402.03 Million | 410.92 Million | 415.69 Million | 407.63 Million | 401 Million |
| Gross Margin | 0.61 | 0.58 | 0.54 | 0.57 | 0.56 | 0.64 |
| EBIT Margin | 0.32 | 0.33 | 0.30 | 0.22 | - | 0.41 |
| Profit Margin | 0.27 | 0.27 | 0.24 | 0.17 | 0.23 | 0.37 |
| EBITDA | 113.37 Million | 130.51 Million | 99.38 Million | 75.83 Million | - | 150.97 Million |
| Earnings Before Tax Margin | 0.30 | 0.27 | 0.30 | 0.19 | 0.26 | 0.40 |
7501
RARE
2941
DIB
7746
MILDEF